Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Publicaciones realizadas por los miembros de la Fundación.
Ruiz-Moreno M, Rúa MJ, Castillo I, García-Novo MD, Santos M, Navas S,Carreño V. Hepatology 1992; 16: 882-885.
Virus de la hepatitis C y crioglobulinemia.
Ortiz A, Quiroga JA, García Delgado R,Carreño V, Caramelo C. Rev Clín Esp 1992; 190: 157.
Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Carreño V, Tapia L, Ryff JC, Quiroga JA, Castillo I. J Med Virol 1992; 37: 215-219.
Protein composition of hepatitis B virus e antigen in the natural course of the disease and following interferon therapy.
Campillo ML, Quiroga JA, Bartolomé J, Moraleda G, Castillo I,Carreño V. J Clin Microbiol 1992; 30: 1256-1261.
Reactivación del virus B de la hepatitis en portadores crónicos con anti-HBe.
Porres JC,Carreño V, Moreno A, Bartolomé J. Rev Clin Esp 1991; 189: 68-72.
Analysis of hepatitis B virus DNA, liver disease and influence of antibody to hepatitis C virus in anti-HBe chronic carriers.
Moraleda G, Bartolomé J, Molina J, Castillo I,Carreño V. Liver 1991; 11: 352-357.
Analysis of serum pre-S antigens in chronic hepatitis B virus infection in relation to the expression pattern of hepatitis B virus DNA in the liver.
Escudero MM, Quiroga JA, Bartolomé J,Carreño V. Digestion 1991; 49: 204-211.
Estudio controlado de tratamiento con interferon alfa recombinante en la hepatitis crónica por virus B en la infancia
Carreño V, Porres JC, Ruiz-Moreno M, Gutiez J, Bartolomé J. Rev Esp Enf Digest 1991; 79: 24-28.
Detection of antibody to calmodulin in chronic viral hepatitis: lack of correlation with virus replication and hepatocellular damage.
Diez A, Quiroga JA, Melero M, Moraleda G, Castillo I, Porres JC,Carreño V. Digestion 1991; 49: 125-133.
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
Quiroga JA, Campillo ML, Castillo I, Bartolomé J, Porres JC,Carreño V. Hepatology 1991; 14: 38-43.
Treatment of chronic hepatitis B with alpha interferon: Present and future.
Carreño V, Quiroga JA. J Hepatol 1991; 13: S2.
Prospective randomized controlled trial of alpha interferon in children with chronic hepatitis B
Ruiz-Moreno M, Rua MJ, Molina J, Moraleda G, Moreno A, García-Aguado J,Carreño V. Hepatology 1991; 13: 1035-1039.
Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection
Castillo I, Bartolomé J, Madejón A, Melero M, Porres JC,Carreño V. Digestion 1991; 48: 149-156.
High doses of recombinant alpha interferon or gamma interferon for chronic hepatitis C: a randomized controlled trial.
Saez-Royuela F, Porres JC, Moreno A, Castillo I, Martinez G, Galiana F,Carreño V. Hepatology 1991; 13: 327-331.
Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children.
Ruiz-Moreno M, Rúa MJ,Carreño V, Quiroga JA, Manns M, Meyer zum Büschenfelde KH. J Hepatol 1991; 12: 265-266.
Detection of serum inhibitory factor for lymphocyte stimulation in chronic viral hepatitis: relationship with the replication level
Martínez MG, Castillo I, Quiroga JA, Porres JC,Carreño V. Liver 1991; 11: 48-52.
Comparative study of three doses of interferon alpha-2A in chronic active hepatitis B. En: Viral Hepatitis and Liver Disease
Thomas HC, Dusheiko GM, Lok ASF, Farrell GC, Williams SJ, Cooksley WGE, Pérez V, Tanno H,Carreño V, Ryff JC. F.BHollinger, S.MLemon, HMargolis, edsWilliams and Wilkins, Baltimore, MD, 1991: 641-642.
nfluence of hepatitis delta virus replication in the presence of hepatitis B virus DNA in peripheral blood mononuclear cells.
Moraleda G, Bartolomé J, Martínez MG, Porres JC,Carreño V. I Hepatology 1990; 12: 1290-1294.
Vacunas frente al virus de la hepatitis B
Carreño V, Quiroga JA. Problemas pendientesRevClinEsp1990; 187: 247-248.
Prolonged treatment (18 months) of chronic hepatitis C with recombinant a-interferon in comparison with a control group.
Gómez Rubio M, Porres JC, Castillo I, Quiroga JA, Moreno A,Carreño V. J Hepatol 1990; 11 (S1): s63-s67.